Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Replicel Life Sciences Inc (RP.VN)

Replicel Life Sciences Inc (RP.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Replicel Life Sciences Inc 570 Granville Street Suite 900 Vancouver BC V6C 3P1 CAN

https://www.replicel.com P: 604-248-8730 F: 604-248-8690

Description:

RepliCel Life Sciences Inc is a Canadian regenerative medicine company. It focuses on developing autologous cell therapies that treat functional cellular deficits. The company addresses various diseases such as chronic tendon injuries, androgenetic alopecia, and skin aging. Its development program of the company is based on distinct technology that utilizes cells isolated from a patient's healthy hair follicles. Also, the company develops a programmable cell injector device designed for dermal injections of cells, dermal filler products, and a variety of other products injected through the skin. The treatments delivered by the company use autologous cell therapy which is developed for the treatment of androgenetic alopecia. The revenue is generated from Licensing fees.

Key Statistics

Overview:

Market Capitalization, $K 3,575
Shares Outstanding, K 65,002
Annual Sales, $ 354 K
Annual Net Income, $ -743 K
Last Quarter Sales, $ 88 K
Last Quarter Net Income, $ -819 K
60-Month Beta -0.06
% of Institutional Shareholders 0.89%

Growth:

1-Year Return -67.65%
3-Year Return -87.50%
5-Year Return -82.26%

Per-Share Information:

Latest Earnings Date N/A
Earnings Per Share ttm -0.02
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year -100.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 08/10/16

RP.VN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % N/A
Return-on-Assets % -17.58%
Profit Margin % -210.11%
Debt/Equity N/A
Price/Sales 7.19
Price/Book N/A
Book Value/Share -0.10
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar